News

NEW YORK (GenomeWeb News) – Illumina’s board appointed Michel Bouchard Chief Accounting Officer, effective Jan. 1. He will continue to serve as vice president of finance for the firm, as well, a title he has held since joining Illumina in 2008.

Before landing at Illumina, Bouchard held senior finance and accounting positions at Websense, and was VP Finance and Accounting from 2007 to 2008.


Sequenom has promoted several members of its management team.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Chan Zuckerberg Initiative is investing in Cold Spring Harbor Laboratory's BioRxiv.

A study appearing in PLOS One finds that shortened consent forms don't affect clinical trial participants' understanding of the study.

The National Security Agency monitored signal intelligence for signs of "nefarious" genetic engineering projects, Gizmodo reports.

In Nature this week: barley genome sequenced, method for genotyping and phasing short tandem repeats, and more.